← Back to headlines
Trinity Biotech Expands PrePsia Patent Portfolio to Nine Patents
Diagnostics company Trinity Biotech announced the expansion of its PrePsia patent portfolio, strengthening its intellectual property position in rapid testing technologies.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
